JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C000464200 on July 27, 2000

J. Biol. Chem., Vol. 275, Issue 39, 29935-29937, September 29, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/39/29935    most recent
C000464200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Proenza, C.
Right arrow Articles by Beam, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Proenza, C.
Right arrow Articles by Beam, K. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ACCELERATED PUBLICATION
Excitation-Contraction Coupling Is Not Affected by Scrambled Sequence in Residues 681-690 of the Dihydropyridine Receptor II-III Loop*

Catherine ProenzaDagger §, Christina M. Wilkens, and Kurt G. Beam||

From the Departments of Dagger  Physiology and  Anatomy and Neurobiology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523

Received for publication, July 14, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A peptide corresponding to residues 681-690 of the II-III loop of the skeletal muscle dihydropyridine receptor alpha 1 subunit (DHPR, alpha 1S) has been reported to activate the skeletal muscle ryanodine receptor (RyR1) in vitro. Within this region of alpha 1S, a cluster of basic residues, Arg681-Lys685, was previously reported to be indispensable for the activation of RyR1 in microsomal preparations and lipid bilayers. We have used an intact alpha 1S subunit with scrambled sequence in this region of the II-III loop (alpha 1S-scr) to test the importance of residues 681-690 and the basic motif for skeletal-type excitation-contraction (EC) coupling and retrograde signaling in vivo. When expressed in dysgenic myotubes (which lack endogenous alpha 1S), alpha 1S-scr restored calcium currents that were indistinguishable, in current density and voltage dependence, from those restored by wild-type alpha 1S. The scrambled DHPR also rescued skeletal-type EC coupling, as indicated by electrically evoked contractions in the presence of 0.5 mM Cd2+ and 0.1 mM La3+. Furthermore, the release of intracellular Ca2+, as assayed by the indicator dye, Fluo-3, had similar kinetics and voltage dependence for alpha 1S and alpha 1S-scr. These data suggest that residues 681-690 of the alpha 1S II-III loop are not essential in muscle cells for normal functioning of the DHPR, including skeletal-type EC coupling and retrograde signaling.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Excitation-contraction (EC)1 coupling in skeletal and cardiac muscle involves a functional interaction between dihydropyridine receptors (DHPRs), voltage-gated L-type calcium channels in the sarcolemma, and ryanodine receptors (RyRs), calcium release channels in the sarcoplasmic reticulum membrane. The mechanism of EC coupling differs in skeletal and cardiac muscle. In cardiac muscle, calcium influx through the pore-forming subunit of the cardiac DHPR (alpha 1C) activates RyRs (1). However, in skeletal muscle, EC coupling is independent of the entry of extracellular Ca2+ (2) and may result instead from a mechanical coupling between the skeletal DHPR alpha 1 subunit (alpha 1S) and the skeletal muscle RyR isoform (RyR1). Expression of alpha 1S/alpha 1C chimeras in dysgenic myotubes (which lack endogenous alpha 1 subunits) has established that skeletal-type EC coupling depends upon skeletal sequence within the putative cytoplasmic region between repeats II and III (II-III loop, amino acids 666-791 (3)). Chimeric DHPRs in which smaller segments of the skeletal DHPR were substituted into the cardiac DHPR subsequently identified residues 720-765 within the II-III loop as critical for activation of skeletal-type EC coupling (4, 5). Moreover, this same critical region is essential for "retrograde signaling," whereby RyR1 enhances the current density of alpha 1S (6). On the other hand, observations in vitro indicate that a different region of the II-III loop, residues 671-690 ("peptide A"), is important for activation of RyR1, as indicated by ryanodine binding, single channel activity, and calcium release (7-9). Within peptide A, residues 681-690 have been identified as the "minimum essential region" of the DHPR II-III loop for activating ryanodine binding and Ca2+ release (10), and it has been suggested that the integrity of a cluster of five basic residues (Arg681-Lys685) is requisite for this region to serve as the physiological trigger for skeletal-type EC coupling (10, 11). In an attempt to determine whether the specific sequence of residues 681-690 and the integrity of the cluster of positively charged residues are required for EC coupling in vivo, we have constructed a full-length DHPR with a scrambled sequence in residues 681-690 (alpha 1S-scr). Dysgenic myotubes expressing alpha 1S or alpha 1S-scr did not differ in calcium current density, voltage dependence of activation, electrically evoked contractions, or voltage dependence of intracellular calcium release. These results indicate that neither the specific sequence of these residues, nor the integrity of the cluster of positive charges, is required for skeletal-type EC coupling in muscle cells.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

An expression plasmid encoding the pore-forming subunit of the skeletal muscle DHPR (alpha 1S (12)) with scrambled residues 681-690 (alpha 1S-scr) was constructed by overlapping PCR mutagenesis (13) using alpha 1S as template. This construct is schematically illustrated in Fig. 1A. The internal forward and reverse primers encoding the scrambled sequence were 5'-AAGGCCAAGGCCGAGGAGAGGAAAATGAGGTCGAGGGGCAAGCTTCGC-3' and 5'-CTTCTCCTCCTCTCTCTTGTCAGGGCGAAGCTTGCCCCTCGACCTCAT-3'. The mutagenized product was amplified using the primer pair 5'-GGGTCCTTCTTCATCCTCAACCTGGTGCTGGGC-3' and 5'-GAGGATCTTTACCACGGAGATGGTGCTGGACT-3'. This final PCR product was digested with XhoI and EcoRI and was ligated into an expression plasmid encoding green fluorescent protein (GFP) fused to the N terminus of alpha 1S (GFP-alpha 1S (14)). For this, GFP-alpha 1S was digested with EcoRI (at nucleotide 1007 in the alpha 1S coding sequence, generated by a partial digest) and XhoI (at nucleotide 2653 in the alpha 1S coding sequence). The altered region of alpha 1S-scr was confirmed by automated DNA sequencing.

Primary cultures of myotubes were prepared from newborn dysgenic mice as described previously (15). Approximately 1 week after plating, plasmids carrying cDNA for wild-type or mutant DHPRs (0.1-0.2 µg/µl) were microinjected into single nuclei. 36-72 h after injection, myotubes expressing DHPRs were identified by accumulation of green fluorescence. Expressing cells bathed in tissue culture medium (Dulbecco's modified Eagle's medium, Sigma) were examined for ability to contract in response to electrical stimulation (80-90 V, 10-30 ms). In some cases, 0.5 mM CdCl2 and 0.1 mM LaCl3 were added to the medium to block Ca2+ influx through DHPRs.

Macroscopic Ca2+ currents and intracellular Ca2+ transients were measured simultaneously (16) using borosilicate glass patch pipettes with resistances of 1.5-3.0 MOmega when filled with an internal solution containing (in mM) 1 MgCl2, 145 cesium glutamate, 10 HEPES, 2 CsCl, 0.1 EGTA, and 0.5 K5-Fluo-3 (Molecular Probes, Eugene, OR). The composition of the bath solution was 10 CaCl2, 145 tetraethylammonium chloride, 0.003 tetrodotoxin, and 10 HEPES (pH 7.4 with tetraethylammonium hydroxide). In some experiments, 0.5 mM CdCl2 and 0.1 mM LaCl3 were added to the extracellular solution. The voltage clamp command sequence was to step from a holding potential of -80 mV to -30 mV for 1 s, to -50 mV for 30 ms, to the test potential for 200 ms, and back to -80 mV. Test currents were digitally corrected for linear leakage and capacitive currents. Ca2+ currents were normalized by linear cell capacitance (pA/pF). All data are presented as mean ± S.E.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

To test the importance of residues 681-690 for DHPR channel function, for retrograde signaling, and for EC coupling, we constructed a mammalian expression plasmid encoding the full-length pore-forming subunit of the skeletal DHPR (alpha 1S) with a scrambled sequence in this region (alpha 1S-scr, Fig. 1A). Note that the cluster of charged residues present in the wild-type sequence has been disrupted in alpha 1S-scr. Whole-cell calcium currents recorded from dysgenic myotubes expressing alpha 1S-scr closely resembled those recorded from myotubes expressing wild-type alpha 1S (Fig. 1B) and, like the wild-type currents, were abolished by application of 0.5 mM Cd2+ and 0.1 mM La3+ (data not shown). Fig. 1C compares average peak I-V relationships for the two constructs, showing that they were similar in both voltage dependence and magnitude. Peak current densities at +40 mV were -5.06 ± 1.12 pA/pF (n = 14) and -5.11 ± 0.74 pA/pF (n = 10) for alpha 1S and alpha 1S-scr, respectively.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Scrambled sequence in the DHPR II-III loop does not alter calcium channel properties of the skeletal muscle dihydropyridine receptor. A, top, schematic illustration of the DHPR alpha 1S subunit with the region of the II-III loop investigated indicated by a bold line. Bottom, sequence of residues 681-690 in the full-length alpha 1S and alpha 1S-scr constructs used in this study. B, representative whole-cell calcium currents recorded from dysgenic myotubes expressing alpha 1S (left) or alpha 1S-scr (right) in response to a voltage step to +40 mV. C, neither the average current density nor the voltage dependence of activation of alpha 1S is altered by scrambled sequence in residues 681-690. Peak current densities for 14 cells expressing alpha 1S (open circles) and 10 cells expressing alpha 1S-scr (filled circles) are shown.

To assay the ability of alpha 1S-scr to mediate skeletal-type EC coupling, dysgenic myotubes expressing either alpha 1S or alpha 1S-scr were tested both for contraction in response to extracellular stimulation and for depolarization-induced Ca2+ release. As illustrated in Fig. 2, wild-type alpha 1S restored evoked contractions in 70% of fluorescent cells tested and alpha 1S-scr restored contractions in 79% of cells tested. Myotubes expressing either alpha 1S (67%) or alpha 1S-scr (53%) retained the ability to contract even after the addition of 0.5 mM Cd2+ and 0.1 mM La3+ to the bathing medium to block Ca2+ entry.


View larger version (70K):
[in this window]
[in a new window]
 
Fig. 2.   Scrambled sequence in the II-III loop does not prevent the ability of DHPRs to restore EC coupling to dysgenic myotubes. Dysgenic myotubes expressing either alpha 1S or alpha 1S-scr were bathed in normal medium (gray bars) or in medium containing 0.5 mM Cd2+ and 0.1 mM La3+ (hatched bars). The cells were stimulated electrically (10 ms, 90 V), and the percentage observed to contract is indicated.

As a further test of whether alpha 1S-scr differs from alpha 1S, we measured intracellular Ca2+ release in voltage-clamped cells by recording changes in fluorescence of the Ca2+ indicator dye, Fluo-3. In both normal medium and medium containing Cd2+ and La3+, calcium transients generated by alpha 1S-scr were similar, in time course and size, to those produced by wild-type alpha 1S (Fig. 3, A-D). The voltage dependence of calcium release was also similar and for both constructs showed a sigmoidal response that saturated at strong depolarizations (Fig. 3E).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Scrambled sequence in the II-III loop does not alter the ability of DHPRs to elicit voltage-activated intracellular calcium release. Representative Fluo-3 fluorescent transients recorded from myotubes injected with either alpha 1S (A, C) or alpha 1S-scr (B, D) and stimulated by a series of test pulses from -20 to +80 mV. Delta F is given in arbitrary units and is the same for all traces. E, the voltage dependence of the intracellular Ca2+ release is not changed by scrambled residues 681-690. Normalized change in fluorescence (Delta F) is plotted as a function of voltage for alpha 1S (open circles, n = 6) and alpha 1S-scr (filled circles, n = 13).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this paper we have shown by expression in muscle cells that wild-type alpha 1S and alpha 1S-scr (alpha 1S with scrambled sequence in residues 681-690 of the II-III loop) do not differ in density or voltage dependence of calcium currents or in skeletal-type EC coupling, as indicated by evoked contractions in Cd2+/La3+ and by voltage dependence of intracellular Ca2+ release. Thus, the function of alpha 1S as a calcium channel and its ability to participate in EC coupling appear to be unaffected by either the specific sequence of residues 681-690 or the integrity of a cluster of basic residues in this region.

The ability of alpha 1S-scr to mediate skeletal-type EC coupling is consistent with earlier work on alpha 1S/alpha 1C chimeras, which showed that strong skeletal-type EC coupling occurred when a critical domain of the II-III loop, residues 720-765, was skeletal in origin (4, 5). The ability of these chimeras to produce skeletal coupling was independent of whether there was skeletal or cardiac sequence for residues 681-690. The interchangeability of cardiac and skeletal sequence in this region could simply be a consequence of sequence conservation or could mean that the sequence of these residues is unimportant for skeletal-type EC coupling. The present results strongly support the latter conclusion.

In vitro studies have shown that RyR1 is activated by a peptide composed of residues 681-690 (see Fig. 1A; Ref. 10) or by a slightly larger peptide (peptide A; residues 671-690 (7-9)). This activation is dependent on the integrity of a group of five basic residues within this region (10, 11). We have now shown that skeletal-type EC coupling still occurs in muscle cells expressing alpha 1S bearing a scrambled sequence in the peptide A region, even though the same scrambled sequence abolished the ability of residues 681-690 to activate RyR1 (10). Thus it seems unlikely that in vitro activation of RyR1 by peptides implies in vivo activation of RyR1 by the corresponding region of the II-III loop. The activation by loop peptides may occur as a consequence of action at sites inaccessible to the intact II-III loop or may result from free solution conformations of the peptides that do not occur natively.

In conclusion, it is clear from our results that residues 681-690 are not required for EC coupling in vivo. However, our results do not exclude the possibility that residues 681-690 play some role in EC coupling, since moderate decreases in calcium release or efficacy of EC coupling would be difficult to detect with our methods.

    ACKNOWLEDGEMENTS

We thank Katherine Parsons and Lindsay Grimes for expert technical assistance.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant NS24444 (to K. G. B.) with a minority supplement (for C. P.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: School of Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.

|| To whom correspondence and reprint requests should be addressed: Dept. of Anatomy and Neurobiology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523. Tel.: 970-491-5277; Fax: 970-491-7907; E-mail: kbeam@lamar.colostate.edu.

Published, JBC Papers in Press, July 27, 2000, DOI 10.1074/jbc.C000464200

    ABBREVIATIONS

The abbreviations used are: EC, excitation-contraction; DHPR, dihydropyridine receptor; RyR, ryanodine receptor; GFP, green fluorescent protein; PCR, polymerase chain reaction; F, farad(s).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Nabauer, M., Callewaert, G., Cleemann, L., and Morad, M. (1989) Science 244, 800-803
2. Armstrong, C. M., Bezanilla, F. M., and Horowicz, P. (1972) Biochim. Biophys. Acta. 267, 605-608
3. Tanabe, T., Beam, K. G., Adams, B. A., Niidome, T., and Numa, S. (1990) Nature 346, 567-569
4. Nakai, J., Tanabe, T., Konno, T., Adams, B., and Beam, K. G. (1998) J. Biol. Chem. 273, 24983-24986
5. Grabner, M., Dirksen, R. T., Suda, N., and Beam, K. G. (1999) J. Biol. Chem. 274, 21913-21919
6. Nakai, J., Dirksen, R. T., Nguyen, H. T., Pessah, I. N., Beam, K. G., and Allen, P. D. (1996) Nature 380, 72-75
7. El-Hayek, R., Antoniu, B., Wang, J., Hamilton, S. L., and Ikemoto, N. (1995) J. Biol. Chem. 270, 22116-22118
8. Dulhunty, A. F., Laver, D. R., Gallant, E. M., Casarotto, M. G., Pace, S. M., and Curtis, S. (1999) Biophys. J. 77, 189-203
9. Casarotto, M. G., Gibson, F., Pace, S. M., Curtis, S. M., Mulcair, M., and Dulhunty, A. F. (2000) J. Biol. Chem. 275, 11631-11637
10. El-Hayek, R., and Ikemoto, N. (1998) Biochemistry 37, 7015-7020
11. Zhu, X., Gurrola, G., Jiang, M. T., Walker, J. W., and Valdivia, H. H. (1999) FEBS Lett. 450, 221-226
12. Tanabe, T., Takeshima, H., Mikami, A., Flockerzi, V., Takahashi, H., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., and Numa, S. (1987) Nature 328, 313-318
13. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 51-59
14. Grabner, M., Dirksen, R. T., and Beam, K. G. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 1903-1908
15. Adams, B. A., and Beam, K. G. (1989) J. Gen. Physiol. 94, 429-444
16. Garcia, J., and Beam, K. G. (1994) J. Gen. Physiol. 103, 107-123


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Biophys. JHome page
S. Pouvreau, L. Csernoch, B. Allard, J. M. Sabatier, M. De Waard, M. Ronjat, and V. Jacquemond
Transient Loss of Voltage Control of Ca2+ Release in the Presence of Maurocalcine in Skeletal Muscle
Biophys. J., September 15, 2006; 91(6): 2206 - 2215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Papadopoulos, V. Leuranguer, R. A. Bannister, and K. G. Beam
Mapping Sites of Potential Proximity between the Dihydropyridine Receptor and RyR1 in Muscle Using a Cyan Fluorescent Protein-Yellow Fluorescent Protein Tandem as a Fluorescence Resonance Energy Transfer Probe
J. Biol. Chem., October 15, 2004; 279(42): 44046 - 44056.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. F. Dulhunty, S. M. Curtis, S. Watson, L. Cengia, and M. G. Casarotto
Multiple Actions of Imperatoxin A on Ryanodine Receptors: INTERACTIONS WITH THE II-III LOOP "A" FRAGMENT
J. Biol. Chem., March 19, 2004; 279(12): 11853 - 11862.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Avila, E. H. Lee, C. F. Perez, P. D. Allen, and R. T. Dirksen
FKBP12 Binding to RyR1 Modulates Excitation-Contraction Coupling in Mouse Skeletal Myotubes
J. Biol. Chem., June 13, 2003; 278(25): 22600 - 22608.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, E. Esteve, J.-M. Sabatier, M. Ronjat, M. De Waard, P. D. Allen, and I. N. Pessah
Maurocalcine and Peptide A Stabilize Distinct Subconductance States of Ryanodine Receptor Type 1, Revealing a Proportional Gating Mechanism
J. Biol. Chem., April 25, 2003; 278(18): 16095 - 16106.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Proenza, J. O'Brien, J. Nakai, S. Mukherjee, P. D. Allen, and K. G. Beam
Identification of a Region of RyR1 That Participates in Allosteric Coupling with the alpha 1S (CaV1.1) II-III Loop
J. Biol. Chem., February 15, 2002; 277(8): 6530 - 6535.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. Ahern, J. Arikkath, P. Vallejo, C. A. Gurnett, P. A. Powers, K. P. Campbell, and R. Coronado
Intramembrane charge movements and excitation- contraction coupling expressed by two-domain fragments of the Ca2+ channel
PNAS, May 18, 2001; (2001) 111001898.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. M. Wilkens, N. Kasielke, B. E. Flucher, K. G. Beam, and M. Grabner
Excitation-contraction coupling is unaffected by drastic alteration of the sequence surrounding residues L720-L764 of the alpha 1S II-III loop
PNAS, April 24, 2001; (2001) 101618098.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Yamamoto and N. Ikemoto
T-tubule Depolarization-induced Local Events in the Ryanodine Receptor, as Monitored with the Fluorescent Conformational Probe Incorporated by Mediation of Peptide A
J. Biol. Chem., January 4, 2002; 277(2): 984 - 992.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yamamoto, J. Rodriguez, and N. Ikemoto
Ca2+-dependent Dual Functions of Peptide C. THE PEPTIDE CORRESPONDING TO THE Glu724-Pro760 REGION (THE SO-CALLED DETERMINANT OF EXCITATION-CONTRACTION COUPLING) OF THE DIHYDROPYRIDINE RECEPTOR alpha 1 SUBUNIT II-III LOOP
J. Biol. Chem., January 4, 2002; 277(2): 993 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. M. Wilkens, N. Kasielke, B. E. Flucher, K. G. Beam, and M. Grabner
Excitation-contraction coupling is unaffected by drastic alteration of the sequence surrounding residues L720-L764 of the alpha 1S II-III loop
PNAS, May 8, 2001; 98(10): 5892 - 5897.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. Ahern, J. Arikkath, P. Vallejo, C. A. Gurnett, P. A. Powers, K. P. Campbell, and R. Coronado
Intramembrane charge movements and excitation- contraction coupling expressed by two-domain fragments of the Ca2+ channel
PNAS, June 5, 2001; 98(12): 6935 - 6940.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/39/29935    most recent
C000464200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Proenza, C.
Right arrow Articles by Beam, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Proenza, C.
Right arrow Articles by Beam, K. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.